Analysts at Zacks Investment Research upgraded shares of Trovagene Inc. (NASDAQ: TROV) from Hold to Buy today. With a rating of Buy on the shares, the company has a 52-week high of $7.18. A number of other analysts have issued …

Shares of Trovagene Inc. (NASDAQ: TROV) were downgraded by analysts at Zacks Investment Research in a note to their investors today.With a rating of Hold on the stock, the company has a 52-week high of $7.22. The one-year price target …